Theratechnologies Inc. (THTX)

Theratechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 21, 2025	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019
Market Capitalization	85	78	206	313	178	235
Market Cap Growth	165.35%	-62.16%	-34.17%	75.91%	-24.35%	-50.30%
Enterprise Value	103	113	235	318	206	243
Last Close Price	1.84	1.58	8.52	13.20	9.20	12.64
PS Ratio	1.01	0.95	2.57	4.48	2.69	3.72
PB Ratio	-4.34	-3.73	-9.12	17.61	55.16	9.47
EV/Sales Ratio	1.23	1.38	2.93	4.55	3.12	3.85
EV/EBITDA Ratio	7.19	-	-	-	-	-
EV/EBIT Ratio	8.70	-	-	-	-	-
Debt / Equity Ratio	-2.94	-2.83	-2.96	3.20	17.18	2.04
Debt / EBITDA Ratio	3.93	-	-	-	-	-
Asset Turnover	1.33	0.96	0.75	0.64	0.61	0.55
Inventory Turnover	3.06	1.52	0.98	0.68	0.96	1.32
Quick Ratio	0.94	1.15	0.41	1.20	0.81	1.37
Current Ratio	1.08	1.34	0.64	2.04	1.55	2.05
Return on Equity (ROE)	-	-	-	-302.37%	-161.57%	-41.76%
Return on Assets (ROA)	11.76%	-6.33%	-23.48%	-14.38%	-10.31%	-4.65%
Return on Capital (ROIC)	27.17%	-13.17%	-42.05%	-23.70%	-16.73%	-6.66%
Return on Capital Employed (ROCE)	70.69%	-	-	-	-	-
Earnings Yield	-3.70%	-30.74%	-22.94%	-10.14%	-12.75%	-5.32%
FCF Yield	-1.76%	-7.69%	-7.61%	-5.64%	-7.64%	-1.96%
Buyback Yield / Dilution	-87.34%	-10.58%	-3.14%	-19.95%	-0.08%	-1.30%
Total Shareholder Return	-87.34%	-10.58%	-3.14%	-19.95%	-0.08%	-1.30%

Source: S&P Capital IQ. Standard template. Financial Sources.